hamaudol has been researched along with beta-Mangostin in 1 studies
| Studies (hamaudol) | Trials (hamaudol) | Recent Studies (post-2010) (hamaudol) | Studies (beta-Mangostin) | Trials (beta-Mangostin) | Recent Studies (post-2010) (beta-Mangostin) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 11 | 0 | 5 |
| Protein | Taxonomy | hamaudol (IC50) | beta-Mangostin (IC50) |
|---|---|---|---|
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HC; Cho, SC; Choi, BY; Fei, X; Keum, YS; Kim, HJ; Lee, K; Seo, SY | 1 |
1 other study(ies) available for hamaudol and beta-Mangostin
| Article | Year |
|---|---|
Discovery of α-mangostin as a novel competitive inhibitor against mutant isocitrate dehydrogenase-1.
Topics: Binding, Competitive; Drug Discovery; Humans; Isocitrate Dehydrogenase; MCF-7 Cells; Molecular Structure; Mutation; Recombinant Proteins; Structure-Activity Relationship; Xanthones | 2015 |